Tech Center 1600 • Art Units: 1629
This examiner grants 70% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19453621 | COMBINATION THERAPY FOR A DOPAMINE AGONIST | Non-Final OA | Alto Neuroscience, Inc. |
| 18559184 | WDR5 INHIBITORS AND MODULATORS | Final Rejection | Vanderbilt University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy